In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19
- PMID: 33372181
- PMCID: PMC7769971
- DOI: 10.1038/s41598-020-79645-9
In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19
Abstract
In the genome of SARS-CoV-2, the 5'-terminus encodes a polyprotein, which is further cleaved into 15 non-structural proteins whereas the 3' terminus encodes four structural proteins and eight accessory proteins. Among these 27 proteins, the present study aimed to discover likely antigenic proteins and epitopes to be used for the development of a vaccine or serodiagnostic assay using an in silico approach. For this purpose, after the full genome analysis of SARS-CoV-2 Wuhan isolate and variant proteins that are detected frequently, surface proteins including spike, envelope, and membrane proteins as well as proteins with signal peptide were determined as probable vaccine candidates whereas the remaining were considered as possible antigens to be used during the development of serodiagnostic assays. According to results obtained, among 27 proteins, 26 of them were predicted as probable antigen. In 26 proteins, spike protein was selected as the best vaccine candidate because of having a signal peptide, negative GRAVY value, one transmembrane helix, moderate aliphatic index, a big molecular weight, a long-estimated half-life, beta wrap motifs as well as having stable, soluble and non-allergic features. In addition, orf7a, orf8, and nsp-10 proteins with signal peptide were considered as potential vaccine candidates. Nucleocapsid protein and a highly antigenic GGDGKMKD epitope were identified as ideal antigens to be used in the development of serodiagnostic assays. Moreover, considering MHC-I alleles, highly antigenic KLNDLCFTNV and ITLCFTLKRK epitopes can be used to develop an epitope-based peptide vaccine.
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.Hum Vaccin Immunother. 2021 Apr 3;17(4):1097-1108. doi: 10.1080/21645515.2020.1823777. Epub 2020 Nov 11. Hum Vaccin Immunother. 2021. PMID: 33175614 Free PMC article.
-
Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.Front Immunol. 2021 Aug 23;12:692937. doi: 10.3389/fimmu.2021.692937. eCollection 2021. Front Immunol. 2021. PMID: 34497604 Free PMC article.
-
Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.Front Immunol. 2020 Oct 28;11:587615. doi: 10.3389/fimmu.2020.587615. eCollection 2020. Front Immunol. 2020. PMID: 33193414 Free PMC article.
-
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein.J Immunol Res. 2024 May 29;2024:9313267. doi: 10.1155/2024/9313267. eCollection 2024. J Immunol Res. 2024. PMID: 38939745 Free PMC article. Review.
-
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development.Arch Med Res. 2021 Jan;52(1):15-24. doi: 10.1016/j.arcmed.2020.09.010. Epub 2020 Sep 10. Arch Med Res. 2021. PMID: 32950264 Free PMC article. Review.
Cited by
-
Spike protein mutational landscape in India during the complete lockdown phase: Could Muller's ratchet be a future game-changer for COVID-19?Infect Genet Evol. 2021 Aug;92:104874. doi: 10.1016/j.meegid.2021.104874. Epub 2021 Apr 24. Infect Genet Evol. 2021. PMID: 33905891 Free PMC article.
-
Bioinformatics-Driven mRNA-Based Vaccine Design for Controlling Tinea Cruris Induced by Trichophyton rubrum.Pharmaceutics. 2024 Jul 25;16(8):983. doi: 10.3390/pharmaceutics16080983. Pharmaceutics. 2024. PMID: 39204328 Free PMC article.
-
Multifaceted Assessment of Wastewater-Based Epidemiology for SARS-CoV-2 in Selected Urban Communities in Davao City, Philippines: A Pilot Study.Int J Environ Res Public Health. 2022 Jul 19;19(14):8789. doi: 10.3390/ijerph19148789. Int J Environ Res Public Health. 2022. PMID: 35886640 Free PMC article.
-
ORF8 and Health Complications of COVID-19 in Down Syndrome Patients.Front Genet. 2022 Feb 9;13:830426. doi: 10.3389/fgene.2022.830426. eCollection 2022. Front Genet. 2022. PMID: 35222544 Free PMC article. No abstract available.
-
Engineering receptor-binding domain and heptad repeat domains towards the development of multi-epitopes oral vaccines against SARS-CoV-2 variants.PLoS One. 2024 Aug 15;19(8):e0306111. doi: 10.1371/journal.pone.0306111. eCollection 2024. PLoS One. 2024. PMID: 39146295 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous